comparemela.com

Latest Breaking News On - National essential medicines committee - Page 1 : comparemela.com

Coronavirus – South Africa: Concern Over Rising COVID-19 Infections in the Western Cape – AfricaBusiness com

Coronavirus – South Africa: Concern Over Rising COVID-19 Infections in the Western Cape – AfricaBusiness com
africabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from africabusiness.com Daily Mail and Mail on Sunday newspapers.

Coronavirus - South Africa: Concern Over Rising COVID-19 Infections in the Western Cape

Covid-19: Ivermectin obsession is dangerous

The obsessive pressure being put on the South African Health Products Regulatory Authority (SAHPRA) to approve ivermectin is extraordinary and dangerous. There are circumstances when early or even illegal access to drugs is justified. In the early 2000s, I worked with the TAC to import fluconazole, a life-saving anti-fungal drug that was obscenely priced in the country. A decade ago we advocated for pre-approval access to a TB drug called bedaquiline. I’ve written extensively on the subject including a peer-reviewed paper: Anything to Stay Alive: The Challenges of a Campaign for an Experimental Drug. So you might think I’d be sympathetic to the push for ivermectin to treat Covid-19.

No guarantee for unregulated use of ivermectin

No guarantee for unregulated use of ivermectin As there is no formulation of ivermectin for human use available in South Africa, the ivermectin being used is either for veterinary use or sourced from illegal importation. Thursday, 28 January 2021, 15:55 File image NATIONAL NEWS - In a statement release on 28 January, SAHPRA (South African Health Products Regulatory Authority) warns that unregulated use of ivermectin cannot be guaranteed as there is no guidance for use. It refers to anecdotal reports of ivermectin replacing other proven therapies as well as reports of falsified and substandard products being sold and used as ivermectin. This is their full statement:

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.